Journal of Clinical Medicine (Aug 2022)

Polymorphisms of the 11q23.3 Locus Affect the Risk and Mortality of Coronary Artery Disease

  • Tomasz Iwanicki,
  • Joanna Iwanicka,
  • Anna Balcerzyk-Matić,
  • Tomasz Nowak,
  • Katarzyna Mizia-Stec,
  • Paweł Bańka,
  • Artur Filipecki,
  • Jolanta Krauze,
  • Alicja Jarosz,
  • Sylwia Górczyńska-Kosiorz,
  • Anna Ochalska-Tyka,
  • Iwona Żak,
  • Paweł Niemiec

DOI
https://doi.org/10.3390/jcm11154532
Journal volume & issue
Vol. 11, no. 15
p. 4532

Abstract

Read online

Background: The present study aimed to determine whether the polymorphisms of the 11q23.3 locus affect the risk and mortality of coronary artery disease in 5-year and 10-year observations. Methods: The study group consisted of 519 subjects: 276 patients with CAD and 243 blood donors as controls. The genotyping of polymorphisms (rs10750097, rs3741298, and rs1729410) was performed using the TaqMan-PCR method. Survival was defined as the period from the angiographic confirmation of CAD to cardiovascular death, and the endpoint was defined as death from cardiovascular causes. Results: The G allele of the rs1729410 polymorphism increased the risk of CAD (OR = 1.55, p = 0.04) and showed a synergistic correlation with overweight/obesity (additive synergy index (SI) = 11.01, p p < 0.001). In the case of the rs10750097 variant, an effect on mortality was shown in both 5-year and 10-year periods. Conclusion: The results revealed that the rs1729410 polymorphism increases the risk of CAD in synergy with traditional risk factors, and the rs10750097 polymorphism of the 11q23.3 locus affects the risk of death in patients with CAD.

Keywords